NRX Pharmaceuticals Inc (NRXP)

[4MVault]

Here is all you need to know....
1. NRXP had a joint agreement to develop ZYESAMI/AVIPTADIL
2. Relief quit paying payments to fund development.
3. NRXP continued development while no longer being funded by Relief.
4. Now at the finish line, Relief is looking to re-partner with NRXP

Regardless of the outcome with the NRXP and Relief, once FDA approval,
The product will be in high demand, causing the stock of NRFP to rise.
Eventually the legal issues will get ironed out.

Buy low, sell high